This study explored the burden of psoriasis on Brazilian patients through an online survey conducted between May 2022 and January 2023, involving 563 individuals diagnosed with psoriasis. The survey focused on self-assessed disease severity, quality of life (QoL), and capability, alongside various demographic and clinical factors. Findings revealed that participants, with a mean age of 42, reported significant challenges such as pain, anxiety, and depression. The average QoL score was 0.59, and the capability score was 0.71, both of which were negatively correlated with self-assessed disease severity (Simplified Psoriasis Index, saSPI). Notably, factors such as high saSPI scores, multiple psoriasis flares, comorbidities, female gender, Black ethnicity, and unemployment were identified as significant predictors of reduced QoL and capability.

The study also highlighted the social stigma, powerlessness, and barriers to adequate care that many participants faced, exacerbating their condition. Over 80% of participants reported some level of pain or discomfort, and 86% struggled with anxiety and depression. The findings underscored the importance of increasing awareness, improving access to treatment, and addressing public misconceptions about psoriasis in Brazil. The researchers concluded that the physical, emotional, and social challenges associated with psoriasis have a profound impact on patients’ quality of life, urging for better healthcare access and support systems.

Reference: Silva JBD, Wright AK, Carvalho AVE, et al. Experience of living with psoriasis in Brazil: a Global Psoriasis Atlas online survey. Int J Dermatol. 2025 Feb;64(2):325-332. doi: 10.1111/ijd.17387. Epub 2024 Jul 17. PMID: 39021244; PMCID: PMC11771568.